Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.83
-0.09 (-0.76%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Replimune Group Employees
Replimune Group had 465 employees as of March 31, 2026. The number of employees decreased by 14 or -2.92% compared to the previous year.
Employees
465
Change (1Y)
-14
Growth (1Y)
-2.92%
Revenue / Employee
n/a
Profits / Employee
-$675,140
Market Cap
990.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 465 | -14 | -2.92% |
| Mar 31, 2025 | 479 | 148 | 44.71% |
| Mar 31, 2024 | 331 | 47 | 16.55% |
| Mar 31, 2023 | 284 | 78 | 37.86% |
| Mar 31, 2022 | 206 | 54 | 35.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| Janux Therapeutics | 108 |
| Lexicon Pharmaceuticals | 81 |
| Inventiva | 77 |
REPL News
- 1 day ago - Replimune upgraded to Outperform from Market Perform at Leerink - TheFly
- 5 days ago - Why Is Replimune (REPL) Stock Up Today? - TipRanks
- 5 days ago - Piper upgrades Replimune to Overweight on better odds of RP1 approval - TheFly
- 5 days ago - Replimune upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 5 days ago - This Biotech Stock Is Soaring 132% After Key FDA Panel Vote on Skin Cancer Treatment - Barrons
- 5 days ago - Replimune price target raised to $12 from $9 at Wedbush - TheFly
- 5 days ago - Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today? - TipRanks
- 5 days ago - Replimune surges after FDA advisers back skin cancer drug - Reuters